BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11975981)

  • 1. HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases.
    Blancheteau V; Charron D; Mooney N
    Hum Immunol; 2002 May; 63(5):375-83. PubMed ID: 11975981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
    Drénou B; Blancheteau V; Burgess DH; Fauchet R; Charron DJ; Mooney NA
    J Immunol; 1999 Oct; 163(8):4115-24. PubMed ID: 10510346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling through MHC class II molecules blocks CD95-induced apoptosis.
    Catlett IM; Xie P; Hostager BS; Bishop GA
    J Immunol; 2001 May; 166(10):6019-24. PubMed ID: 11342618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis.
    Gómez-Angelats M; Cidlowski JA
    J Biol Chem; 2001 Nov; 276(48):44944-52. PubMed ID: 11581255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A; Berard M; Casamayor-Pallejà M; Krammer PH; Defrance T
    J Immunol; 2000 Sep; 165(6):3023-30. PubMed ID: 10975811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.
    Sprick MR; Rieser E; Stahl H; Grosse-Wilde A; Weigand MA; Walczak H
    EMBO J; 2002 Sep; 21(17):4520-30. PubMed ID: 12198154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
    Strauss G; Knape I; Melzner I; Debatin KM
    J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
    Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT
    Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
    Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
    Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
    Shain KH; Landowski TH; Dalton WS
    J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of c-FLIP in modulation of CD95-induced apoptosis.
    Scaffidi C; Schmitz I; Krammer PH; Peter ME
    J Biol Chem; 1999 Jan; 274(3):1541-8. PubMed ID: 9880531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two CD95 (APO-1/Fas) signaling pathways.
    Scaffidi C; Fulda S; Srinivasan A; Friesen C; Li F; Tomaselli KJ; Debatin KM; Krammer PH; Peter ME
    EMBO J; 1998 Mar; 17(6):1675-87. PubMed ID: 9501089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell receptor cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein.
    Besnault L; Schrantz N; Auffredou MT; Leca G; Bourgeade MF; Vazquez A
    J Immunol; 2001 Jul; 167(2):733-40. PubMed ID: 11441077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.
    Scaffidi C; Schmitz I; Zha J; Korsmeyer SJ; Krammer PH; Peter ME
    J Biol Chem; 1999 Aug; 274(32):22532-8. PubMed ID: 10428830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H pylori receptor MHC class II contributes to the dynamic gastric epithelial apoptotic response.
    Bland DA; Suarez G; Beswick EJ; Sierra JC; Reyes VE
    World J Gastroenterol; 2006 Aug; 12(29):4689-93. PubMed ID: 16937440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity.
    Kirchhoff S; Müller WW; Krueger A; Schmitz I; Krammer PH
    J Immunol; 2000 Dec; 165(11):6293-300. PubMed ID: 11086065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
    Sprick MR; Weigand MA; Rieser E; Rauch CT; Juo P; Blenis J; Krammer PH; Walczak H
    Immunity; 2000 Jun; 12(6):599-609. PubMed ID: 10894160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in human Burkitt lymphoma B cells BL41.
    Schrantz N; Bourgeade MF; Mouhamad S; Leca G; Sharma S; Vazquez A
    Mol Biol Cell; 2001 Oct; 12(10):3139-51. PubMed ID: 11598198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.
    Lajmanovich A; Irisarri M; Molens JP; Pasquier MA; Sotto JJ; Bensa JC; Leroux D; Plumas J
    Br J Haematol; 2004 Mar; 124(6):746-53. PubMed ID: 15009062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.